Volkan Adsay Selected Research

Carcinoma (Carcinomatosis)

2/2023	Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis.
1/2022	Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis.
5/2020	Poorly Cohesive (Signet Ring Cell) Carcinoma of the Ampulla of Vater.
7/2019	Lipase hypersecretion syndrome: A distinct form of paraneoplastic syndrome specific to pancreatic acinar carcinomas.
9/2017	Reflux-Associated Cholecystopathy: Analysis of 76 Gallbladders From Patients With Supra-Oddi Union of the Pancreatic Duct and Common Bile Duct (Pancreatobiliary Maljunction) Elucidates a Specific Diagnostic Pattern of Mucosal Hyperplasia as a Prelude to Carcinoma.
1/2017	Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
1/2016	Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated.
2/2015	Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma: implications for management and prognosis.
4/2014	Adenocarcinoma of the minor duodenal papilla and its precursor lesions: a clinical and pathologic study.
11/2013	Early gallbladder carcinoma has a favorable outcome but Rokitansky-Aschoff sinus involvement is an adverse prognostic factor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Volkan Adsay Research Topics

Disease

43	Neoplasms (Cancer) 04/2024 - 01/2001
17	Adenocarcinoma 04/2024 - 10/2003
16	Carcinoma (Carcinomatosis) 02/2023 - 01/2001
13	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 10/2003
6	Neoplasm Metastasis (Metastasis) 07/2019 - 01/2009
5	Neoplasms, Cystic, Mucinous, and Serous 03/2021 - 01/2001
4	Cysts 01/2022 - 12/2011
3	Adenoma (Adenomas) 01/2022 - 07/2004
3	Carcinogenesis 01/2022 - 05/2003
3	Polyps 03/2021 - 01/2020
3	Fibrosis (Cirrhosis) 08/2012 - 08/2003
2	Cholangiocarcinoma 04/2024 - 11/2019
2	Colonic Neoplasms (Colon Cancer) 03/2024 - 03/2023
2	Rectal Neoplasms (Rectal Cancer) 03/2024 - 01/2022
2	Medullary Carcinoma 01/2023 - 11/2020
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 08/2015
2	Metaplasia 01/2021 - 01/2020
2	Pancreatitis 01/2021 - 09/2017
2	Hyperplasia 01/2021 - 09/2017
2	Neuroendocrine Carcinoma 11/2019 - 03/2010
2	Pancreatic Cyst 11/2019 - 01/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 07/2019
2	Acinar Cell Carcinoma 07/2019 - 09/2016
2	Ischemia 10/2017 - 03/2007
2	Serous Cystadenoma 11/2014 - 12/2011
2	Breast Neoplasms (Breast Cancer) 05/2007 - 08/2003
1	Lymphatic Metastasis 04/2024
1	Extranodal Extension 03/2024
1	Hemangiosarcoma (Angiosarcoma) 01/2024
1	Residual Neoplasm 12/2022
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 12/2022
1	Choledochal Cyst (Choledochal Cysts) 01/2022
1	Gallstones (Gallstone) 01/2022
1	Carcinoma in Situ 07/2021
1	Cholangitis 01/2021
1	Microsatellite Instability 01/2021
1	Autolysis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Paraganglioma (Paragangliomas) 09/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Jaundice (Icterus) 11/2019

Drug/Important Bio-Agent (IBA)

8	MucinsIBA 01/2022 - 08/2003
8	EnzymesIBA 01/2022 - 12/2005
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2003
3	CholesterolIBA 03/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 11/2019 - 01/2001
3	Mucin-1 (CA 15-3 Antigen)IBA 07/2017 - 07/2004
3	Cisplatin (Platino)FDA LinkGeneric 09/2016 - 12/2003
2	CateninsIBA 07/2022 - 12/2012
2	phytobacteriomycin (PBM)IBA 01/2022 - 09/2017
2	Bile Pigments (Bilin)IBA 07/2021 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2016
2	LipidsIBA 09/2020 - 03/2008
2	Keratins (Keratin)IBA 01/2020 - 01/2016
2	VimentinIBA 01/2020 - 06/2012
2	Fetal Proteins (Fetoprotein)IBA 11/2019 - 08/2016
2	ChromatinIBA 11/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 01/2019
2	Lipase (Acid Lipase)FDA Link 07/2019 - 12/2012
2	TrypsinIBA 07/2019 - 12/2012
2	Phosphotransferases (Kinase)IBA 12/2017 - 10/2003
2	CAM 5.2 antigenIBA 07/2017 - 03/2017
2	Glycoproteins (Glycoprotein)IBA 03/2017 - 09/2004
2	Monoclonal AntibodiesIBA 10/2016 - 01/2009
2	Phenobarbital (Luminal)FDA Link 10/2016 - 11/2012
2	Gemcitabine FDA Link 09/2016 - 12/2005
2	ParaffinIBA 08/2016 - 01/2016
2	GadoliniumIBA 08/2012 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 12/2011 - 03/2008
2	ErbB Receptors (EGF Receptor)IBA 05/2007 - 05/2003
1	4-nitrophenylphosphorylcholine (NPPC)IBA 04/2024
1	tyramine-deoxysorbitolIBA 03/2024
1	beta CateninIBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2022
1	CyclinsIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 03/2021
1	Histone-Lysine N-MethyltransferaseIBA 01/2021
1	Fixatives (Pickling Agents)IBA 01/2021
1	LigandsIBA 11/2020
1	PlatinumIBA 06/2020
1	Cadherins (E-Cadherin)IBA 05/2020
1	bis(diazo)benzidine (BDB)IBA 11/2019
1	BilirubinIBA 11/2019

Therapy/Procedure

8	Therapeutics 01/2023 - 12/2005
7	Cholecystectomy 02/2023 - 08/2011
7	Drug Therapy (Chemotherapy) 06/2020 - 08/2003
5	Pancreaticoduodenectomy 04/2024 - 11/2012
4	Neoadjuvant Therapy 12/2022 - 01/2021
3	Pancreatectomy 01/2024 - 03/2012
3	Radiotherapy 03/2010 - 12/2003
2	Chemoradiotherapy 08/2015 - 12/2003
1	Lymph Node Excision (Lymph Node Dissection) 04/2024
1	Splenectomy 01/2024
1	Adjuvant Chemotherapy 03/2023
1	Precision Medicine 01/2022
1	Immunotherapy 01/2021